scholarly journals Reduced Blood Pressure and Increased Sensitivity of the Vasculature to Parathyroid Hormone-Related Protein (PTHrP) in Transgenic Mice Overexpressing the PTH/PTHrP Receptor in Vascular Smooth Muscle*

Endocrinology ◽  
1999 ◽  
Vol 140 (4) ◽  
pp. 1826-1833 ◽  
Author(s):  
Jin Qian ◽  
John N. Lorenz ◽  
Shigeto Maeda ◽  
Roy L. Sutliff ◽  
Craig Weber ◽  
...  
2013 ◽  
Vol 305 (3) ◽  
pp. F333-F342 ◽  
Author(s):  
Denis Raison ◽  
Catherine Coquard ◽  
Mazène Hochane ◽  
Jacques Steger ◽  
Thierry Massfelder ◽  
...  

Parathyroid hormone-related protein (PTHrP) belongs to vasoactive factors that regulate blood pressure and renal hemodynamics both by reducing vascular tone and raising renin release. PTHrP is expressed in systemic and renal vasculature. Here, we wanted to assess the contribution of vascular smooth muscle cell endogenous PTHrP to the regulation of cardiovascular and renal functions. We generated a mouse strain ( SMA-CreER T2/ PTHrP L2/L2 or premutant PTHrP SM−/−), which allows temporally controlled, smooth muscle-targeted PTHrP knockdown in adult mice. Tamoxifen treatment induced efficient recombination of PTHrP-floxed alleles and decreased PTHrP expression in vascular and visceral smooth muscle cells of PTHrP SM−/− mice. Blood pressure remained unchanged in PTHrP SM−/− mice, but plasma renin concentration and creatinine clearance were reduced. Renal hemodynamics were further analyzed during clearance measurements in anesthetized mice. Conditional knockdown of PTHrP decreased renal plasma flow and glomerular filtration rate with concomitant reduction in filtration fraction. Similar measurements were repeated during acute saline volume expansion. Saline volume expansion induced a rise in renal plasma flow and reduced filtration fraction; both were blunted in PTHrP SM−/− mice leading to impaired diuresis. These findings show that endogenous vascular smooth muscle PTHrP controls renal hemodynamics under basal conditions, and it is an essential factor in renal vasodilation elicited by saline volume expansion.


2008 ◽  
Vol 198 (2) ◽  
pp. 264-271 ◽  
Author(s):  
Jose Luis Martin-Ventura ◽  
Luis Miguel Blanco-Colio ◽  
Cesar Aparicio ◽  
Luis Ortega ◽  
Pedro Esbrit ◽  
...  

Endocrinology ◽  
2012 ◽  
Vol 153 (2) ◽  
pp. 861-872 ◽  
Author(s):  
Brian M. Sicari ◽  
Ronnie Troxell ◽  
Fatimah Salim ◽  
Mansoor Tanwir ◽  
Karen K. Takane ◽  
...  

Parathyroid hormone-related protein (PTHrP) contains a classical bipartite nuclear localization signal. Nuclear PTHrP induces proliferation of arterial vascular smooth muscle cells (VSMC). In the arterial wall, PTHrP is markedly up-regulated in response to angioplasty and promotes arterial restenosis. PTHrP overexpression exacerbates arterial restenosis, and knockout of the PTHrP gene results in decreased VSMC proliferation in vivo. In arterial VSMC, expression of the cell cycle inhibitor, p27, rapidly decreases after angioplasty, and replacement of p27 markedly reduces neointima development. We have shown that PTHrP overexpression in VSMC leads to p27 down-regulation, mostly through increased proteosomal degradation. Here, we determined the molecular mechanisms through which PTHrP targets p27 for degradation. S-phase kinase-associated protein 2 (skp2) and c-myc, two critical regulators of p27 expression and stability, and neointima formation were up-regulated in PTHrP overexpression in VSMC. Normalization of skp2 or c-myc using small interfering RNA restores normal cell cycle and p27 expression in PTHrP overexpression in VSMC. These data indicate that skp2 and c-myc mediate p27 loss and proliferation induced by PTHrP. c-myc promoter activity was increased, and c-myc target genes involved in p27 stability were up-regulated in PTHrP overexpression in VSMC. In primary VSMC, PTHrP overexpression led to increased c-myc and decreased p27. Conversely, knockdown of PTHrP in primary VSMC from PTHrPflox/flox mice led to cell cycle arrest, p27 up-regulation, with c-myc and skp2 down-regulation. Collectively, these data describe for the first time the role of PTHrP in the regulation of skp2 and c-myc in VSMC. This novel PTHrP-c-myc-skp2 pathway is a potential target for therapeutic manipulation of the arterial response to injury.


Sign in / Sign up

Export Citation Format

Share Document